Need professional-grade analysis? Visit stockanalysis.com
$899.04M
N/A
N/A
N/A
Jade Biosciences, Inc. (JBIO) trades on United States in USD. The company is classified in the Healthcare sector under the Pharmaceutical Preparations industry. The stock currently trades at $22.85, up 4.43% from the previous close.
Over the past year, JBIO has traded between a low of $6.76 and a high of $94.13. The stock has lost 75.7% over this period. It is currently 75.7% below its 52-week high.
Jade Biosciences, Inc. has a market capitalization of $899.04M.
Jade Biosciences, Inc. operates as a biotechnology company that develops therapies for inflammation and immunology indications in patients living with autoimmune diseases. It develops JADE101, a monoclonal antibody to block the A PRoliferation Inducing Ligand protein, which is in phase 1 clinical trial. The compnay also develops JADE201 and JADE-003, which are in preclinical development stage. Jade Biosciences, Inc. has a collaboration agreement with Paragon Therapeutics, Inc. Jade Biosciences, Inc. is based in Waltham, Massachusetts.
Side-by-side comparison against top Healthcare peers.